相关实验视频
Updated: May 28, 2025

09:52
Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity
Published on: March 16, 2018
9.3K
使用cimetidine来减轻西斯胺诱导的耳毒性
Rahul Sinha1, Si Ja Liu2, Rebekah Lee2
1Department of Otolaryngology, Philadelphia College of Osteopathic Medicine, Philadelphia, PA 19131, United States of America.
概括
齐米蒂丁可以通过阻断耳朵细胞中的有机阴离子载体2 (OCT2) 来预防西斯普拉丁诱导的听力损失. 这种方法可以降低耳毒性,而不会影响西斯的抗癌疗效.
科学领域:
- 耳毒性研究研究
- 药理学 药理学是指药理学的学科.
- 治疗癌症的治疗方法
背景情况:
- 西斯是一种重要的化疗药物,但其使用受到耳毒性 (内耳损伤) 的限制.
- 有机阴离子转运体2 (OCT2) 促进青进入内耳细胞,导致耳毒性.
- 齐米蒂丁是一种FDA批准的药物,已知可以抑制OCT2活性.
研究的目的:
- 通过抑制OCT2.2,研究cimetidine是否可以通过抑制OCT2.2来预防cisplatin诱导的耳毒性.
- 评估这种保护作用是否影响西斯丁对癌细胞的疗效.
主要方法:
- 使用的家用耳部研究所 - 科尔蒂的器官1 (HEI-OC1) 细胞系来建模内耳细胞.
- 在暴露于西斯普拉丁和西米蒂丁后评估细胞活力.
- 评估了西斯丁和西米蒂丁对癌症细胞系的联合作用.
主要成果:
- 西斯普拉丁以剂量依赖的方式降低了HEI-OC1细胞活力.
- 在HEI-OC1细胞中,西美提丁抵消了西斯胺诱导的耳毒性.
- 齐米蒂丁没有干扰西斯普拉丁对癌细胞的细胞毒性作用.
结论:
- 用cimetidine抑制OCT2显示出减轻西斯普拉丁诱导的耳毒性有望.
- 组合疗法可能为接受西斯治疗的癌症患者减少听力损失提供一种策略.
- 这种方法可以提高青化疗的治疗指数.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
173
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
173
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
147
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
147
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
200
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
200
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
215
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
215
Drugs that Destabilize Microtubules
1.9K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
1.9K

